Primary epithelioid sarcoma of bone: report of a unique case, with immunohistochemical and fluorescent in situ hybridization confirmation of INI1 deletion.
Primary epithelioid sarcoma of bone: report of a unique case, with immunohistochemical and fluorescent in situ hybridization confirmation of INI1 deletion.
复制标题
原发性骨上皮样肉瘤:一个独特病例的报告,免疫组织化学和荧光原位杂交证实了 INI1 缺失。
DOI:
10.1097/pas.0b013e31819b92d5
复制
发表时间:
2009
期刊:
影响因子:
--
通讯作者:
A. Folpe
中科院分区:
文献类型:
--
作者:
D. Raoux;M. Péoc'h;F. Pedeutour;B. Vaunois;A. Decouvelaere;A. Folpe
We report the clinical and pathologic features of, what is to the best of our knowledge, the first case of epithelioid sarcoma of bone. A 31-year-old woman with an unremarkable past medical history presented with pelvic pain and was found by computed tomography scan to have a destructive 5 cm, partially calcified intraosseous lesion of the iliac bone. Histologically, the tumor consisted of relatively uniform but clearly malignant-appearing epithelioid cells, with scattered rhabdoid-appearing cells. A hyalinized to partially calcified matrix was present between the tumor cells, with a "chickenwire" pattern of calcification. By immunohistochemistry, the neoplastic cells expressed cytokeratins, vimentin, epithelial membrane antigen and CD34, and showed complete loss of INI1 protein expression. Fluorescence in situ hybridization showed homozygous deletion of the INI1 gene. An extensive clinical and radiographic workup did not show evidence of a soft tissue tumor, and the diagnosis of a primary epithelioid sarcoma of bone was made. After this, the patient underwent a complete resection of her tumor, and is currently disease free, 6 months after surgery. These extremely rare tumors must be rigorously distinguished from other more common tumors of bone, in particular, chondroblastoma and osteosarcoma. Awareness that epithelioid sarcoma may occur in bone, careful histologic evaluation and ancillary immunohistochemistry for epithelial markers, CD34 and INI1 protein should allow for recognition of such tumors. Study of additional cases of primary epithelioid sarcoma of bone will be necessary to better understand its clinical behavior.
登录
查看更多内容
影响因子:
3.3
作者:
Kohashi, Kenichi;Izumi, Teiyu;Tsuneyoshi, Masazumi
通讯作者:
Tsuneyoshi, Masazumi
DOI:
--
发表时间:
2006
期刊:
Mod Pathol 19
影响因子:
--
作者:
Teiyu Izumi;Tadashi Hasegawa;et al.
通讯作者:
et al.
DOI:
--
发表时间:
2007
期刊:
Journal of Cancer Research and Clinical Oncology 133
影响因子:
--
作者:
Kohashi K;Oda Y;et. al.
通讯作者:
et. al.
DOI:
--
发表时间:
2006
期刊:
Pathology International 56
影响因子:
--
作者:
Oda Y;Tsuneyoshi M
通讯作者:
Tsuneyoshi M